|
Symbol Name ID |
Tle3
transducin-like enhancer of split 3 MGI:104634 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Tle2tm1(KOMP)Vlcg/Tle2tm1(KOMP)Vlcg Tle3tm1.1Pton/Tle3tm1.1Pton Tg(Pdx1-cre)6Tuv/0 involves: 129P2/OlaHsd * C57BL/6 * FVB/N |
decreased pancreatic beta cell number | J:307817 |
| impaired glucose tolerance | J:307817 | |
| Tle3tm1.1Pton/Tle3tm1.1Pton Tle4tm1.1Dasw/Tle4tm1.1Dasw Tg(Pdx1-cre)6Tuv/0 involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N |
abnormal pancreas development | J:307817 |
| abnormal pancreatic beta cell differentiation | J:307817 | |
| abnormal pancreatic islet morphology | J:307817 | |
| decreased pancreatic beta cell mass | J:307817 | |
| decreased pancreatic beta cell number | J:307817 | |
| decreased pancreatic beta cell proliferation | J:307817 | |
| disorganized pancreatic islets | J:307817 | |
| normal growth/size/body region phenotype | J:307817 | |
| hyperglycemia | J:307817 | |
| impaired glucose tolerance | J:307817 | |
| postnatal lethality, incomplete penetrance | J:307817 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||